HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
about
Molecular mechanisms involved in farnesol-induced apoptosisSynergistic induction of apoptosis by HMG-CoA reductase inhibitor and histone deacetylases inhibitor in HeLa cellsIron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseasesNovel synthetic inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity that inhibit tumor cell proliferation and are structurally unrelated to existing statinsInhibiting HDAC1 Enhances the Anti-Cancer Effects of Statins through Downregulation of GGTase-Iβ ExpressionStatins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activationLovastatin protects human endothelial cells from the genotoxic and cytotoxic effects of the anticancer drugs doxorubicin and etoposideThe Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination.Lovastatin prevents bleomycin-induced DNA damage to HepG2 cells.Short-term high-dose effect of lovastatin on thrombolysis by rt-PA in a human whole-blood in vitro clot model.The prince and the pauper. A tale of anticancer targeted agents.Rho inhibition by lovastatin affects apoptosis and DSB repair of primary human lung cells in vitro and lung tissue in vivo following fractionated irradiationStatin use and mortality of patients with prostate cancer: a meta-analysis.
P2860
Q24655100-8D042227-2885-4BE3-847B-669FEB42E300Q28383033-74654ABE-D43E-49A3-ABBB-F4B289346CE4Q28388335-3A3CE7B3-E622-4DA2-B3F5-C10918443111Q33507292-47943028-CDF1-465E-A76A-57B790219EB5Q33755131-0FAD618F-B7A8-4E75-9D00-EDE782120F84Q35828643-44646C43-FE34-4642-AC29-42F666CB84CCQ36054324-B7FFF7B0-41B5-4567-B005-B48B2BC2AE9AQ36090448-E46C4531-99B9-4991-8FFD-9B8AC4C2C97DQ36230902-0B93B053-B50F-4B6E-9B4E-BF7E6F761681Q36876792-BA221C54-698D-4F23-9796-70F55FC7F085Q37042365-F975C65C-4EE1-4FCE-A99E-3C54AAA82513Q38630699-8564B2A3-84DB-44AA-BCF2-8C9714B47A44Q39506823-20B06192-E833-40A2-A87A-35DCD9FF9FB1
P2860
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
@ast
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
@en
type
label
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
@ast
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
@en
prefLabel
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
@ast
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review).
@en
P1476
HMG-CoA reductase inhibitors (statins) as anticancer drugs (review)
@en
P2093
Gerhard Fritz
P304
P577
2005-11-01T00:00:00Z